


| Key | % Net Assets |
|---|---|
| 6.9% | |
| 5.5% | |
| 5.0% | |
| 5.0% | |
| 77.6% |
| Name | % Net Assets |
|---|---|
| AstraZeneca | 6.9% |
| Vodafone Group | 5.5% |
| Resolution | 5.0% |
| BP | 5.0% |
| GlaxoSmithKline | 5.0% |
| Rentokil Initial | 4.1% |
| Morrison Supermarkets | 3.9% |
| Lloyds Banking Group | 3.7% |
| Royal Bank of Scotland Group | 3.5% |
| Barclays | 3.4% |
| Key | % Net Assets |
|---|---|
| 30.00% | |
| 18.00% | |
| 17.40% | |
| 10.10% | |
| 7.80% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 15,490.00p |
| Currency | GBP |
| Change | 0.000p |
| % | n/a |
| YTD change | 2,180.00p |
| YTD % | 16.38% |
| Fund Inception | 31/05/1987 |
|---|---|
| Fund Manager | Kevin Murphy / Nick Kirrage |
| TER | 1.66 (25-Feb-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.12 |
You are here: research